ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 996,64
0,49%
Dow Jones
38 852,27
0,46%
DAX
18 175,21
1,01%
Brent Oil
83,485
0,01%
Bitcoin
63 685,21
0,80%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NeuBase Therapeutics Inc (NBSE)

  7. NeuBase Therapeutics Inc (NBSE) Actualités

NBSE NeuBase Therapeutics Inc

0,4101
0,0051 (1,26%)
07 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
NeuBase Therapeutics Inc NBSE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0051 1,26% 0,4101 01:55:46
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,3766 0,36 0,418 0,4101 0,405
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/5/202413:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/4/202422:05GLOBENeuBase Therapeutics Announces Receipt of Notice from Nasdaq
07/3/202422:01EDGAR2Form 8-K - Current report
23/2/202422:01EDGAR2Form 8-K - Current report
26/1/202414:00EDGAR2Form 8-K - Current report
17/1/202412:15EDGAR2Form 8-K - Current report
28/12/202313:00EDGAR2Form 8-K - Current report
28/12/202312:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/12/202312:15EDGAR2Form 8-K - Current report
27/11/202315:00GLOBEPsychemedics Corporation Appoints Daniella Mehalik as VP -..
09/11/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202323:00EDGAR2Form 8-K - Current report
20/10/202313:30EDGAR2Form 8-K - Current report
18/10/202314:00EDGAR2Form 8-K - Current report
29/9/202322:10EDGAR2Form 8-K - Current report
21/9/202302:42EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
20/9/202323:28EDGAR2Form SC 13D/A - General statement of acquisition of..
18/9/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202322:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/9/202322:17EDGAR2Form 8-K - Current report
14/9/202312:03EDGAR2Form SC 13D/A - General statement of acquisition of..
11/9/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202313:00GLOBENeuBase Therapeutics Issues Statement Regarding Filing By..
07/9/202323:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202316:00PRNUSSYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
31/8/202317:50EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14/8/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202312:18EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/8/202312:15EDGAR2Form DEF 14A - Other definitive proxy statements
10/8/202323:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/8/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202313:05EDGAR2Form 8-K - Current report
01/8/202322:45EDGAR2Form PRE 14A - Other preliminary proxy statements
31/7/202322:10EDGAR2Form 8-K - Current report
28/7/202312:03EDGAR2Form S-1 - General form for registration of securities under..
30/6/202322:21EDGAR2Form 8-K - Current report
30/6/202314:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/6/202314:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Dernières Valeurs Consultées

NASDAQ
NBSE
NeuBase Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés